Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

An Ethical Exploration of Barriers to Research on Controlled Drugs. Am J Bioeth (2016) 5.77

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ (2010) 3.46

The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int (2012) 2.31

Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain (2012) 2.13

Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology (2008) 1.94

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol (2011) 1.88

Adverse effects of medical cannabinoids: a systematic review. CMAJ (2008) 1.86

A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain (2008) 1.82

Marijuana use and motor vehicle crashes. Epidemiol Rev (2011) 1.74

Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci (2013) 1.70

Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Biol Psychiatry (2008) 1.54

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One (2010) 1.44

Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain (2011) 1.40

Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics (2009) 1.36

Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther (2007) 1.26

Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain (2007) 1.25

Medical marijuana: clearing away the smoke. Open Neurol J (2012) 1.21

Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS (2008) 1.17

Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol (2013) 1.16

The analgesic potential of cannabinoids. J Opioid Manag (2010) 1.16

Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology (2013) 1.13

Neurologic presentations of AIDS. Neurol Clin (2010) 1.12

A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo. ChemMedChem (2009) 1.11

MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models. Br J Pharmacol (2008) 1.05

Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag (2008) 1.05

Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. PLoS One (2012) 1.03

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ (2012) 1.03

Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV Study (WIHS) cohort, 1994-2010. J Acquir Immune Defic Syndr (2012) 0.98

Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med (2012) 0.98

An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California. J Drug Policy Anal (2011) 0.97

Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. J Pain (2015) 0.97

Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials. Can Fam Physician (2015) 0.97

Cannabinoid control of neuroinflammation related to multiple sclerosis. Br J Pharmacol (2007) 0.94

HIV-related neuropathy: current perspectives. HIV AIDS (Auckl) (2013) 0.93

Amygdala activity contributes to the dissociative effect of cannabis on pain perception. Pain (2013) 0.92

Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg (2012) 0.89

Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy? Evid Based Complement Alternat Med (2013) 0.88

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict Sci Clin Pract (2015) 0.88

Therapeutic benefits of cannabis: a patient survey. Hawaii J Med Public Health (2014) 0.87

HEAVY MARIJUANA USE AMONG GAY AND BISEXUAL MALE EMERGING ADULTS LIVING WITH HIV/AIDS. J HIV AIDS Soc Serv (2013) 0.86

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther (2013) 0.86

Marijuana Legalization: Impact on Physicians and Public Health. Annu Rev Med (2015) 0.86

Reproducibility of the heat/capsaicin skin sensitization model in healthy volunteers. J Pain Res (2013) 0.85

Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence. J Clin Exp Neuropsychol (2011) 0.85

Cardiac capsaicin-sensitive sensory nerves regulate myocardial relaxation via S-nitrosylation of SERCA: role of peroxynitrite. Br J Pharmacol (2007) 0.84

Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. J Pain (2015) 0.83

Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry (2016) 0.82

Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81

The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J (2013) 0.81

Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems. Pain Ther (2015) 0.81

Prevalence and correlates of "Vaping" as a route of cannabis administration in medical cannabis patients. Drug Alcohol Depend (2016) 0.81

Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances. Neurobehav HIV Med (2012) 0.80

Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain. J Rehabil Res Dev (2009) 0.80

Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. Can Fam Physician (2014) 0.80

Pain, Cannabis Species, and Cannabis Use Disorders. J Stud Alcohol Drugs (2016) 0.80

Cannabinoids for chronic pain. BMJ (2008) 0.79

Sex-dependent effects of cannabis-induced analgesia. Drug Alcohol Depend (2016) 0.79

Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. Neuropsychopharmacology (2017) 0.78

Prescribing cannabis for harm reduction. Harm Reduct J (2012) 0.78

The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. J Addict (2015) 0.78

A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain. J Neurol (2014) 0.77

Opioid and cannabinoid synergy in a mouse neuropathic pain model. Br J Pharmacol (2016) 0.77

Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. Neuropharmacology (2014) 0.77

The use of cannabinoids in chronic pain. BMJ Case Rep (2013) 0.77

High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting. AIDS Behav (2015) 0.77

Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix. Neuropsychopharmacology (2015) 0.76

Acute effects of cannabis on breath-holding duration. Exp Clin Psychopharmacol (2016) 0.76

Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS. Drug Alcohol Depend (2015) 0.76

Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis. Neurotherapeutics (2015) 0.76

An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. J Pain (2016) 0.76

Medical marijuana: Showdown at the cannabis corral. Nature (2015) 0.76

More evidence cannabis can help in neuropathic pain. CMAJ (2010) 0.76

Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review. AIDS Care (2016) 0.75

Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies. Pain Med (2013) 0.75

Propagation through alginate encapsulation of axillary buds of Cannabis sativa L. - an important medicinal plant. Physiol Mol Biol Plants (2009) 0.75

Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. Parkinsons Dis (2016) 0.75

Medical cannabis - the Canadian perspective. J Pain Res (2016) 0.75

Antinociceptive effects of topical mepivacaine in a rat model of HIV-associated peripheral neuropathic pain. J Pain Res (2016) 0.75

Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain. Front Pharmacol (2017) 0.75

A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. J Pain Res (2016) 0.75

Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. Harm Reduct J (2017) 0.75

Pain in amaXhosa women living with HIV/AIDS: a cross-sectional study of ambulant outpatients. BMC Womens Health (2017) 0.75

Cannabis and Cannabinoids for Chronic Pain. Curr Rheumatol Rep (2017) 0.75

Identifying HIV care enrollees at-risk for cannabis use disorder. AIDS Care (2016) 0.75

[Epidemiology and therapy of pain and depression during HIV and AIDS]. Schmerz (2009) 0.75

Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther (2011) 2.75

Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. Br J Surg (2015) 2.11

Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures. J Virol (1972) 2.09

Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients. Neurology (2006) 1.97

Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies. J Clin Invest (1976) 1.78

Chronic developmental lead exposure reduces neurogenesis in adult rat hippocampus but does not impair spatial learning. Toxicol Sci (2005) 1.77

Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin. Science (1994) 1.73

Neurologic aspects of cocaine abuse. West J Med (1988) 1.71

Sequence determination of the capsid protein gene and flanking regions of tobacco etch virus: Evidence for synthesis and processing of a polyprotein in potyvirus genome expression. Proc Natl Acad Sci U S A (1985) 1.70

Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther (2007) 1.70

Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav (1989) 1.64

What is a "clinically meaningful" reduction in pain? Pain (2001) 1.57

Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol (1994) 1.55

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain (1999) 1.45

Suicidal behavior and sexual/physical abuse among street youth. Child Abuse Negl (1998) 1.42

Cumulative radiation dose during hospitalization for aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol (2010) 1.42

Medical students' views on selection tools for medical school--a mixed methods study. Ir Med J (2014) 1.41

Advance directives are more likely among seniors asked about end-of-life care preferences. Arch Intern Med (1999) 1.32

Curative cerebrovascular reconstruction with the Pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms. J Neurointerv Surg (2009) 1.28

Atropine occlusion in the treatment of strabismic amblyopia and its effect upon the non-amblyopic eye. Ophthalmic Physiol Opt (1991) 1.28

Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. BMJ (1997) 1.26

A fetal alcohol behavior scale. Alcohol Clin Exp Res (1998) 1.26

A new human experimental pain model: the heat/capsaicin sensitization model. Neuroreport (1999) 1.26

Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain (2000) 1.18

Mitogen-activated protein and tyrosine kinases in the activation of astrocyte volume-activated chloride current. J Neurosci (1998) 1.16

The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Anesth Analg (2000) 1.14

The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol Biochem Behav (1989) 1.13

Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res (2000) 1.12

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Br J Pharmacol (1988) 1.11

gamma-Aminobutyric acid(A) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J Neurochem (2001) 1.10

Effect of remifentanil on pain and secondary hyperalgesia associated with the heat--capsaicin sensitization model in healthy volunteers. Anesthesiology (2001) 1.08

Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist. Pharmacol Biochem Behav (1991) 1.05

Zoster-associated pain and neural dysfunction. Pain (2001) 1.02

A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol (1983) 1.02

Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med (1987) 0.99

Electrophysiological function of the delayed rectifier (IK) in bullfrog sympathetic ganglion neurones. Pflugers Arch (1989) 0.97

Efferent projections of the anterior perirhinal cortex in the rat. J Comp Neurol (1996) 0.97

Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav (1990) 0.96

Purinergic regulation of cation conductances and intracellular Ca2+ in cultured rat retinal pigment epithelial cells. J Physiol (1999) 0.96

Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage (1996) 0.95

Axotomy affects calcium-sensitive potassium conductance in sympathetic neurones. Neurosci Lett (1986) 0.95

Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell Death Dis (2010) 0.95

Comparative cost of myocardial revascularization: percutaneous transluminal angioplasty and coronary artery bypass surgery. J Am Coll Cardiol (1985) 0.94

Effect of intravenous magnesium on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Br J Anaesth (2001) 0.94

Zacopride: anxiolytic profile in rodent and primate models of anxiety. J Pharm Pharmacol (1988) 0.93

DOCSS: doctors on-call smartphone study. Ir J Med Sci (2013) 0.93

Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya. Int J Tuberc Lung Dis (2013) 0.93

Neuropathic pain needs systematic classification. Eur J Pain (2013) 0.93

Anxiolytic-like action of DuP753, a non-peptide angiotensin II receptor antagonist. Neuroreport (1990) 0.91

Marginal sinus arteriovenous fistulas mimicking carotid cavernous fistulas: diagnostic and therapeutic considerations. AJNR Am J Neuroradiol (2007) 0.90

Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Neuroreport (1991) 0.90

Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain (1997) 0.90

Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. J Thromb Haemost (2007) 0.90

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav (1990) 0.90

The effects of axotomy on bullfrog sympathetic neurones. J Physiol (1987) 0.90

Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology (1993) 0.90

Pain caused by herpes zoster infection. Neurol Clin (1998) 0.89

Effect of systemic adenosine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Reg Anesth Pain Med (2001) 0.89

Angiotensin-converting enzyme inhibition, angiotensin, and cognition. J Cardiovasc Pharmacol (1992) 0.88

Association of temperature greater than 41.1 degrees C (106 degrees F) with serious illness. Clin Pediatr (Phila) (1985) 0.88

Successful umbilical cord blood stem cell transplantation in a patient with Rothmund-Thomson syndrome and combined immunodeficiency. Clin Genet (2006) 0.88

FAST and SLOW amygdala kindling rat strains: comparison of amygdala, hippocampal, piriform and perirhinal cortex kindling. Epilepsy Res (1999) 0.88

Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology (1987) 0.88

Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuroprotective effects. Exp Eye Res (2000) 0.87

Blood pressure but not parental history for hypertension predicts pain perception in women. Pain (2000) 0.87

The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists. Pharmacol Biochem Behav (1990) 0.87

Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. Cell Immunol (1995) 0.86

Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth (1996) 0.86

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav (1990) 0.86

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. Pain (2009) 0.86

Coxsackievirus in an infant chimpanzee. J Med Primatol (1978) 0.86

Differential sensitivity of various temporal lobe structures in the rat to kindling and status epilepticus induction. Epilepsy Res (1996) 0.85

K+ and Cl- currents in freshly isolated rat osteoclasts. Pflugers Arch (1991) 0.85

Ketotifen and its analogues reduce aversive responding in the rodent. Pharmacol Biochem Behav (1990) 0.84

Observer variation in the interpretation of lower limb venograms. AJR Am J Roentgenol (1979) 0.83

Trazodone-oral cocaine interactions. Arch Gen Psychiatry (1984) 0.83

The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav (1989) 0.83

A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology (2002) 0.83

Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions. Neurology (2000) 0.83

Calcium-activated potassium current in cultured rabbit retinal pigment epithelial cells. Curr Eye Res (1996) 0.82

Actions of substance P on membrane potential and ionic currents in guinea pig stellate ganglion neurons. Am J Physiol (1998) 0.82

Thalamomesencephalic strokes after cocaine abuse. Neurology (1989) 0.82

1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Nature (1986) 0.82

The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent. Br J Pharmacol (1984) 0.81

Effect of charybdotoxin and leiurotoxin I on potassium currents in bullfrog sympathetic ganglion and hippocampal neurons. Brain Res (1992) 0.81

The anxiolytic and anxiogenic actions of ethanol in a mouse model. J Pharm Pharmacol (1988) 0.81

Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital. J Neurointerv Surg (2009) 0.81

Seizure-induced differential expression of messenger RNAs for neurotrophins and their receptors in genetically fast and slow kindling rats. Neuroscience (1996) 0.81

The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors. Neuropharmacology (1986) 0.81

The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents. J Pharmacol Exp Ther (1997) 0.81

Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia. Acta Derm Venereol (1999) 0.81

The interpretation of pain relief and sensory changes following sympathetic blockade. Brain (1994) 0.81

The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav (1989) 0.81

The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour. Eur J Pharmacol (1992) 0.81